You searched for T - Page 5 of 132

Duchenne Regulatory Science Consortium

Founded in 2015, D-RSC supports collaborative research through shared data access and advances development of drug development too

The Electronic Clinical Outcome Assessment (eCOA) Consortium provides scientific leadership and best practice recommendations surr

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a debilitating genetic disease affecting more than 600,000 Americans and 1

PRO measures assess one or more aspects of a patient’s health status based on information gathered directly from the patient, wi

The Data and Analytics Platform RDCA-DAP houses integrated patient-level data from diverse sources, including clinical trials, lon

Although companies have developed newer methods to test drug safety, these are not globally accepted by the FDA or EMA as proof of

The Rare Disease Clinical Outcome Assessment Consortium enables precompetitive, multi-stakeholder collaboration aimed at identifyi

Critical Path for Alpha-1 Antitrypsin Deficiency CPA-1 is a public-private partnership comprised of industry partners, academic re

The Regualtory Science (RegSci) Program was founded in 2020 to lead regulatory strategy development and supports regulatory submis

The Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development